GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.027
A. Philippidis
{"title":"Gilead to Acquire CymaBay for $4.3B, Adding to Liver Portfolio","authors":"A. Philippidis","doi":"10.1089/genedge.6.01.027","DOIUrl":"https://doi.org/10.1089/genedge.6.01.027","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"17 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140518516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.014
Jonathan D. Grinstein
{"title":"Blood Brothers: Kyverna Reinvents Autologous CAR T Manufacturing from Blood Draw","authors":"Jonathan D. Grinstein","doi":"10.1089/genedge.6.01.014","DOIUrl":"https://doi.org/10.1089/genedge.6.01.014","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"30 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140526508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.032
A. Philippidis
{"title":"StockWatch: Nvidia Shares Leap Again after Reporting Record Revenues","authors":"A. Philippidis","doi":"10.1089/genedge.6.01.032","DOIUrl":"https://doi.org/10.1089/genedge.6.01.032","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"162 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140523119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.020
Jonathan D. Grinstein
{"title":"Light My Fire: COUR Raises $105M Series A to Advance Tolerogenic Nanoparticles for Autoimmunity","authors":"Jonathan D. Grinstein","doi":"10.1089/genedge.6.01.020","DOIUrl":"https://doi.org/10.1089/genedge.6.01.020","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140524170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.015
Jonathan D. Grinstein
{"title":"GSK and Elegen Team Up to Develop DNA-Based Medicines and Vaccines","authors":"Jonathan D. Grinstein","doi":"10.1089/genedge.6.01.015","DOIUrl":"https://doi.org/10.1089/genedge.6.01.015","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"5 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140520252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.036
A. Philippidis
{"title":"StockWatch: Challengers Take Aim at Lilly, Novo Nordisk","authors":"A. Philippidis","doi":"10.1089/genedge.6.01.036","DOIUrl":"https://doi.org/10.1089/genedge.6.01.036","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"56 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140517649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
GEN EdgePub Date : 2024-01-01DOI: 10.1089/genedge.6.01.016
A. Philippidis
{"title":"Drugs, Dollars, and Data: Recursion Eyes Cost Savings from AI Drug Discovery","authors":"A. Philippidis","doi":"10.1089/genedge.6.01.016","DOIUrl":"https://doi.org/10.1089/genedge.6.01.016","url":null,"abstract":"","PeriodicalId":140137,"journal":{"name":"GEN Edge","volume":"3 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140524827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}